Sort
85,873 grants matching “alzheimers”
The Long Life Family Study
$11,510,915Michael A Province · Washington University · U19 · FY2022 · AG
Precision Aging Network: Closing the Gap Between Cognitive Healthspan andHuman Lifespan
$11,488,617Carol A. Barnes · University Of Arizona · U19 · FY2025 · AG
Wisconsin longitudinal study: Initial lifetime's impact on Alzheimer's disease and related disorders (WLS-ILIAD)
$11,478,637Sanjay Asthana · University Of Wisconsin-Madison · R01 · FY2024 · AG
California National Primate Research Center
$11,460,599Prasant Mohapatra · University Of California At Davis · P51 · FY2020 · OD
Wisconsin longitudinal study: Initial lifetime's impact on Alzheimer's disease and related disorders (WLS-ILIAD)
$11,444,831Sanjay Asthana · University Of Wisconsin-Madison · R01 · FY2023 · AG
California National Primate Research Center
$11,401,866Prasant Mohapatra · University Of California At Davis · P51 · FY2019 · OD
Alzheimer's Disease Cooperative Study
$11,393,316William C Mobley · University Of California, San Diego · U19 · FY2015 · AG
HABS-HD - Core C - Clinical Core
$11,344,466Sid E O'Bryant · University Of North Texas Hlth Sci Ctr · U19 · FY2022 · AG
US POINTER Neuroimaging Ancillary Study
$11,343,101Susan M Landau · University Of California Berkeley · R01 · FY2019 · AG
Alzheimer's Disease Cooperative Study
$11,288,568Paul S. Aisen · University Of California, San Diego · U19 · FY2013 · AG
US POINTER Neuroimaging Ancillary Study
$11,232,449Susan M Landau · University Of California Berkeley · R01 · FY2024 · AG
US POINTER Neuroimaging Ancillary Study
$11,190,623Susan M Landau · University Of California Berkeley · R01 · FY2021 · AG
US POINTER Neuroimaging Ancillary Study
$11,146,442Susan M Landau · University Of California Berkeley · R01 · FY2020 · AG
ALZHEIMER'S DISEASE COOPERATIVE STUDY
$11,094,321University Of California San Diego · U01 · FY2002 · AG
DISCOVERY: Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
$11,092,441Natalia S Rost · Massachusetts General Hospital · U19 · FY2020 · NS
Adult Changes in Thought (ACT) Research Program
$11,060,502Linda Kathleen McEvoy · Kaiser Foundation Research Institute · U19 · FY2023 · AG
Adult Changes in Thought (ACT) Research Program
$11,040,953Linda Kathleen McEvoy · Kaiser Foundation Research Institute · U19 · FY2024 · AG
Phase II randomized controlled trial of benfotiamine in early Alzheimer's Disease
$11,038,947Gary E Gibson · Winifred Masterson Burke Med Res Inst · R01 · FY2023 · AG
Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study
$11,000,000Susan Abushakra · Alzheon, Inc. · R01 · FY2022 · AG
PREVENTABLE Clinical Sites Core
$10,980,790Adrian Hernandez · Duke University · U19 · FY2020 · AG
Clinical Core
$10,939,222Paul S. Aisen · Northern California Institute/Res/Edu · U19 · FY2022 · AG
The Human Genome Sequencing Center
$10,896,210Richard A Gibbs · Baylor College Of Medicine · U54 · FY2015 · HG
Adult Changes in Thought (ACT) Research Program
$10,767,047Jennifer Nelson · Kaiser Foundation Research Institute · U19 · FY2022 · AG
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Dementia with Lewy Bodies
$10,764,669Anthony O Caggiano · Cognition Therapeutics, Inc. · R01 · FY2021 · AG
Cognitive training to reduce incidence of cognitive impairment in older adults
$10,740,912Jerri Edwards · University Of South Florida · R01 · FY2023 · AG